Active site-directed thrombin inhibitors: α-hydroxyacylprolyl-arginals. New orally active stable analogs of d-Phe-Pro-Arg-H
Synthesis and evaluation of title compounds are described. Some analogues (e.g. 2) are potent anticoagulants in vitro and show significant oral activities in adose of 5 mg/kg, i.e. delay clotting times and inhibit thrombus formation.
References (35)
- et al.
Tetrahedron Lett.
(1991) - et al.
TIPS
(1993) - Bajusz, S.; Szell, E.; Barabas, E.; Bagdy, D. U.S. Patent 4,478,745,...
- et al.
- et al.
Int. J. Peptide Protein Res.
(1978) - et al.
EMBO J.
(1989) - et al.
FEBS Letters
(1977) - et al.
J. Med. Chem.
(1993) - et al.
J. Med. Chem.
(1990)
Blood Coagulation and Fibrinolysis
(1993)
J. Med. Chem.
(1993)
Cited by (0)
- ∗
Hac = Man (1), Hpl (3), Pla (4), or Hma (5). Reagents; i, MeOH/0.05 equiv. H2SO4; ii, 1 equiv. dihydropyran/0.05 equiv. HCl/EtOAc in CH2Cl2; iii, NaOH/MeOH; iv, HOTcp/DCC in THF; v, coupling in DMF/l equiv. NEt3; vi, mixed anhydride coupling; vii, LiAlH4/THF; viii, H2/Pd in EtOH/0.5 M H2SO4 (1 equiv.); ix, catalyst removed, pH adjusted to 3.6, kept at 20 °C for 24 h.
Copyright © 1995 Published by Elsevier Ltd.